Back to top

LACOG 0920 – Senticol III

  /    /  LACOG 0920 – Senticol III

International Validation Study Of Sentinel Node Biopsy In Early Cervical Cancer

Type of Study: Clinical Trial

Sponsor / Support: Centre Hospitalier Universitaire de Besançon, LACOG

Primary Objectives: Disease-free Survival (iDFS) (non-inferiority) Health-Related Quality of Life (HRQoL) at 3 years

Design: ARM A: Experimental, Histerectomy or Trachelectomy + SLN biopsy only; ARM B: Reference, Histerectomy or Trachelectomy + SLN biopsy + Pelvic Lymphadenectomy

Sample Size: 950 patients (50 Brazil)

Principal Investigator: Gustavo Guitmann

Countries LATAM: Brazil, China, Italia, França, Canada e Japão

Clinicaltrials.gov Identifier: NCT03386734

The study is open to patients participation in the following research sites:

A.C. Camargo Câncer Center / São Paulo / SP / Brazil

INCA - Instituto Nacional de Câncer / Rio de Janeiro / RJ / Brazil

Hospital Erasto Gaertner / Curitiba / PR / Brazil

Hospital do Câncer de Barretos / Barretos / SP / Brazil